Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Passweg

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Internal Medicine|December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemiaC Craddock, J Versluis, M Labopin, et al.
Bone Marrow Transplantation|March 15, 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesA Gratwohl, J Passweg, C Bocelli-Tyndall, et al.
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Annals of the Rheumatic Diseases|July 14, 2004
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR RegistryD Farge, J Passweg, J M van Laar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Internal Medicine|December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemiaC Craddock, J Versluis, M Labopin, et al.
Bone Marrow Transplantation|March 15, 2005
Autologous hematopoietic stem cell transplantation for autoimmune diseasesA Gratwohl, J Passweg, C Bocelli-Tyndall, et al.
Immuno-Oncology Technology|January 13, 2025
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanomaD König, B Kasenda, M Sandholzer, et al.
Bone Marrow Transplantation|July 30, 2013
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practiceT Ruutu, A Gratwohl, T de Witte, et al.
Bone Marrow Transplantation|October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune DiseaseA Tyndall, A Fassas, J Passweg, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.
Annals of the Rheumatic Diseases|July 14, 2004
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR RegistryD Farge, J Passweg, J M van Laar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 11